retatrutide phase 2 results 2024 2025 Want to learn more about the GLP-3 called retatrutide? Not yet FDA approved but soon. A weight loss game changer Yes, we offer Retatrutide!! 🙌 – retatrutide phase 2 obesity trial

10.1098/rstb.2000.0707 Philos

Liraglutide decreases energy expenditure and does not affect the fat fraction of supraclavicular brown adipose tissue in patients with type 2 diabetes

There is one Phase I trial registered as NCT02637284 in 2015, intended to enrol forty-two participants, which was subsequently cancelled with no published results [7]

It is important to screen for Vitamin B12 deficiency because early detection through screening can prevent the symptoms and their progression

Overweight or obesity (BMI 30-plus, or 27-plus with a weight-related condition) where weight loss is the goal and there is no diabetes driving the choice

What makes Tirzepatide a compelling choice for weight loss